US4960423A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of enhancing the attachment of endothelial cells on a matrix and vascular prosthesis with enhanced anti-thrombogenic characteristics
Assignee: Individual
•
Filing: 1982-11-17
•
Granted: 1990-10-02
•
Expires: 2002-11-17
Abstract
Abstract The attachment and growth of endothelial cells on the luminal surface of a vascular prosthesis are enhanced by coating the luminal surface of the vascular prosthesis with peptide derived from elastin. The resultant vascular prosthesis, which may be seeded with endothelial cells just prior to implantation has an enhanced anti-thrombogenic luminal surface.
Inventors
- 👤 Donald W. Smith
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 19:50
CPC Classifications
A; A61; A61L; A61L33/00; A61L33/06; A61L33/12; A61L33/128
Claims Analysis
Total Claims: 15
Claim 1
Independent Claim
72 words
The combination of a synthetic vascular prosthesis having a blood contacting surface and suitable for use as a replacement artery or vein and a resilient coating on the blood contacting surface of said prothesis of a water soluble peptide derived from elastin and having desmosine as part of the structure capable of enhancing the attachment of endothelial cells to said blood-contacting surface, said prosthesis thus having an enhanced anti-thrombogenic blood contacting surface.
Claim 2
Dependent Claim
72 words
The combination of a synthetic vascular prosthesis having a blood contacting surface and suitable for use as a replacement artery or vein and a resilient coating on the blood contacting surface of said prothesis of a water soluble peptide derived from elastin and having desmosine as part of the structure capable of enhancing the attachment of endothelial cells to said blood-contacting surface, said prosthesis thus having an enhanced anti-thrombogenic blood contacting surface.
Claim 3
Dependent Claim
13 words
The combination of claim 1 in which said peptide comprises -elastin, or K-elastin.
Claim 4
Dependent Claim
19 words
The combination of claim 1 in which said peptide is bonded to said blood contacting surface of said matrix.
Claim 5
Dependent Claim
23 words
The combination according to claim 3 in which a bonding agent on said blood contacting surface for bonding said peptide to said matrix.
Claim 6
Dependent Claim
26 words
The combination according to claim 4 in which said bonding agent comprises amino groups, or oxygen containing groups selected from aldehyde, carboxylic acid and hydroxyl groups.
Claim 7
Dependent Claim
33 words
The combination according to claim 3 in which said prosthesis is comprised of a human or animal vein or artery having a bifunctional aldehyde bonded to said blood contacting surface and said peptide.
Claim 8
Dependent Claim
32 words
The combination according to claim 3 in which said prosthesis is comprised of dacron or polytetrafluoroethylene having hydroxyl groups bonded with said peptide and fixing said peptide to said blood contacting surface.
Claim 9
Dependent Claim
55 words
The combination of a non-thrombogenic synthetic vascular prosthesis having a blood contacting surface suitable for use as a replacement artery or vein and a resilient coating on the blood contacting surface of said prosthesis consisting essentially of a desmosine comprising elastin, said peptide being capable of enhancing the attachment of endothelial cells to said surface.
Claim 10
Dependent Claim
55 words
The combination of a non-thrombogenic synthetic vascular prosthesis having a blood contacting surface suitable for use as a replacement artery or vein and a resilient coating on the blood contacting surface of said prosthesis consisting essentially of a desmosine comprising elastin, said peptide being capable of enhancing the attachment of endothelial cells to said surface.
Claim 11
Dependent Claim
20 words
The combination of claim 8 in which said peptide is covalently bonded to said blood contacting surface of said matrix.
Claim 12
Dependent Claim
34 words
The combination according to claim 8 in which said matrix is comprised of a human or animal vein or artery convalently bonded to said blood contacting surface and also covalently bonded to said peptide.
Claim 13
Dependent Claim
18 words
The combination of claim 1 in which said peptide is K-elastin obtained by the alkaline hydrolysis of elastin.
Claim 14
Dependent Claim
26 words
The combination of claim 1 in which said peptide is a coacervate of α-elastin obtained by heating an aqueous solution of α-elastin to about 37° C.
Claim 15
Dependent Claim
40 words
The vascular prosthesis according to claim 8 in which said matrix is comprised of dacron or polytetrafluoroethylene material having hydroxyl groups fixed to said blood contacting surface which covalently bond with said peptide and fix said peptide to said surface.
References Cited (Backward Citations)
US4187852A
Cited
US4329383A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1993-10-01 | 1994-04-02 | 1994-10-02 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1997-10-01 | 1998-04-02 | 1998-10-02 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2001-10-01 | 2002-04-02 | 2002-10-02 | $7700.00 | Window Closed / Lapsed |